25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Er Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Er Therapeutics Inc together

I guess you are interested in Er Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Er Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Er Therapeutics Inc

I send you an email if I find something interesting about Er Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Er Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Er Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.02
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-13,163.1%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0 - $0.0001
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Er Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.00
Intrinsic Value Per Share
$-0.05 - $-0.06
Total Value Per Share
$-0.05 - $-0.06

2.2. Growth of Er Therapeutics Inc (5 min.)




Is Er Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$112.3k$79.3k-$191.7k-170.6%

How much money is Er Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$426.9k-$375.5k-$51.3k-12.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Er Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Other Industrial Metals & Mining industry (5 min.)




  Industry Rankings (Other Industrial Metals & Mining)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Er Therapeutics Inc?

Welcome investor! Er Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Er Therapeutics Inc.

First you should know what it really means to hold a share of Er Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Er Therapeutics Inc is $0.0001. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Er Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Er Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Er Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-7,327.9%-0.01-7,327.9%-0.01-6,446.1%0.00-4,505.1%0.00-4,505.1%
Usd Book Value Change Per Share0.00-3,290.8%0.00-3,290.8%0.002,367.1%0.00-482.2%0.00-482.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-3,290.8%0.00-3,290.8%0.002,367.1%0.00-482.2%0.00-482.2%
Usd Price Per Share0.05-0.05-0.00-0.01-0.01-
Price to Earnings Ratio-6.96--6.96-0.00--1.74--1.74-
Price-to-Total Gains Ratio-15.50--15.50--15.50--15.50-
Price to Book Ratio-26.44--26.44-0.00--6.61--6.61-
Price-to-Total Gains Ratio-15.50--15.50--15.50--15.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0001
Number of shares10000000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10000000 shares)-32,907.80-4,821.52
Gains per Year (10000000 shares)-131,631.20-19,286.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-131631-1316410-19286-19296
20-263262-2632720-38572-38582
30-394894-3949030-57858-57868
40-526525-5265340-77144-77154
50-658156-6581650-96430-96440
60-789787-7897960-115716-115726
70-921418-9214270-135003-135012
80-1053050-10530580-154289-154298
90-1184681-11846890-173575-173584
100-1316312-13163200-192861-192870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.02.00.050.0%2.02.00.050.0%2.02.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.02.00.050.0%2.02.00.050.0%2.02.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Er Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.003-0.0030%0.002-239%0.000-85%0.000-85%
Book Value Per Share---0.002-0.0020%0.001-242%0.000-80%0.000-80%
Current Ratio--0.0010.0010%0.010-93%0.135-100%0.135-100%
Debt To Asset Ratio--1.2651.2650%0.825+53%1.116+13%1.116+13%
Debt To Equity Ratio----0%4.726-100%6.810-100%6.810-100%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--2435515.3002435515.3000%--2435515.3000%2435515.3000%
Eps---0.007-0.0070%-0.006-12%-0.005-39%-0.005-39%
Ev To Ebitda Ratio--infinfnan%--infnan%infnan%
Ev To Sales Ratio--infinfnan%--infnan%infnan%
Free Cash Flow Per Share---0.004-0.0040%-0.004-7%-0.003-36%-0.003-36%
Free Cash Flow To Equity Per Share---0.002-0.0020%-0.002+5%0.000-93%0.000-93%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.059--------
Intrinsic Value_10Y_min---0.050--------
Intrinsic Value_1Y_max---0.004--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.012--------
Intrinsic Value_3Y_min---0.012--------
Intrinsic Value_5Y_max---0.024--------
Intrinsic Value_5Y_min---0.021--------
Market Cap5826.430-50900%2971479.3002971479.3000%-+100%742869.825+300%742869.825+300%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio-0.052+100%-26.444-26.4440%--100%-6.611-75%-6.611-75%
Pe Ratio-0.014+100%-6.960-6.9600%--100%-1.740-75%-1.740-75%
Price Per Share0.000-50900%0.0510.0510%-+100%0.013+300%0.013+300%
Price To Free Cash Flow Ratio-0.025+100%-12.948-12.9480%--100%-3.237-75%-3.237-75%
Price To Total Gains Ratio-0.030+100%-15.498-15.4980%---15.4980%-15.4980%
Quick Ratio----0%-0%0.009-100%0.009-100%
Return On Assets---1.008-1.0080%-0.826-18%-3.081+206%-3.081+206%
Return On Equity----0%-4.7320%-57.0510%-57.0510%
Total Gains Per Share---0.003-0.0030%0.002-239%0.000-85%0.000-85%
Usd Book Value---112369.000-112369.0000%79366.000-242%-22768.000-80%-22768.000-80%
Usd Book Value Change Per Share---0.003-0.0030%0.002-239%0.000-85%0.000-85%
Usd Book Value Per Share---0.002-0.0020%0.001-242%0.000-80%0.000-80%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--2435515.3002435515.3000%--2435515.3000%2435515.3000%
Usd Eps---0.007-0.0070%-0.006-12%-0.005-39%-0.005-39%
Usd Free Cash Flow---229500.000-229500.0000%-213885.000-7%-146977.750-36%-146977.750-36%
Usd Free Cash Flow Per Share---0.004-0.0040%-0.004-7%-0.003-36%-0.003-36%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%-0.002+5%0.000-93%0.000-93%
Usd Market Cap5826.430-50900%2971479.3002971479.3000%-+100%742869.825+300%742869.825+300%
Usd Price Per Share0.000-50900%0.0510.0510%-+100%0.013+300%0.013+300%
Usd Profit---426953.000-426953.0000%-375580.000-12%-262489.000-39%-262489.000-39%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.003-0.0030%0.002-239%0.000-85%0.000-85%
 EOD+2 -6MRQTTM+0 -0YOY+9 -175Y+8 -1910Y+8 -19

3.3 Fundamental Score

Let's check the fundamental score of Er Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.014
Price to Book Ratio (EOD)Between0-1-0.052
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.001
Debt to Asset Ratio (MRQ)Less than11.265
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.008
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Er Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Er Therapeutics Inc

Pengram Corporation, an exploration stage mining company, engages in the acquisition, exploration, and development of natural resource properties, primarily gold. It holds 216 claims covering an area of approximately 4350 acres in 3 properties in Nevada, including the Fish project in Esmeralda County, the CPG project in Mineral County, and the Golden Snow property in Eureka County. The company also has interest in the Clisbako property, which consists of mineral claims covering an area of 8,372 acres in the Cariboo Mining District of British Columbia. Pengram Corporation was founded in 2006 and is based in Bellingham, Washington.

Fundamental data was last updated by Penke on 2024-11-27 14:31:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Er Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Er Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.4%+4.4%
TTM--7.5%+7.5%
YOY--46.6%+46.6%
5Y--173.8%+173.8%
10Y--670.0%+670.0%
4.3.1.2. Return on Assets

Shows how efficient Er Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • -100.8% Return on Assets means that Er Therapeutics Inc generated $-1.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Er Therapeutics Inc:

  • The MRQ is -100.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -100.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-100.8%TTM-100.8%0.0%
TTM-100.8%YOY-82.6%-18.1%
TTM-100.8%5Y-308.1%+207.3%
5Y-308.1%10Y-308.1%0.0%
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ-100.8%-6.4%-94.4%
TTM-100.8%-6.9%-93.9%
YOY-82.6%-6.5%-76.1%
5Y-308.1%-9.3%-298.8%
10Y-308.1%-14.0%-294.1%
4.3.1.3. Return on Equity

Shows how efficient Er Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • 0.0% Return on Equity means Er Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Er Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-473.2%+473.2%
TTM-5Y-5,705.1%+5,705.1%
5Y-5,705.1%10Y-5,705.1%0.0%
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.6%+6.6%
TTM--7.6%+7.6%
YOY-473.2%-7.2%-466.0%
5Y-5,705.1%-9.7%-5,695.4%
10Y-5,705.1%-14.3%-5,690.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Er Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Er Therapeutics Inc is operating .

  • Measures how much profit Er Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Er Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ--105.3%+105.3%
TTM--43.7%+43.7%
YOY--49.3%+49.3%
5Y--265.9%+265.9%
10Y--617.6%+617.6%
4.3.2.2. Operating Ratio

Measures how efficient Er Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other Industrial Metals & Mining industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Er Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.710-1.710
TTM-1.712-1.712
YOY-1.954-1.954
5Y-3.533-3.533
10Y-8.363-8.363
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Er Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Er Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other Industrial Metals & Mining industry mean).
  • A Current Ratio of 0.00 means the company has $0.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Er Therapeutics Inc:

  • The MRQ is 0.001. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.001. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.010-0.009
TTM0.0015Y0.135-0.134
5Y0.13510Y0.1350.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0011.944-1.943
TTM0.0012.053-2.052
YOY0.0102.823-2.813
5Y0.1353.920-3.785
10Y0.1354.512-4.377
4.4.3.2. Quick Ratio

Measures if Er Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Er Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.009-0.009
5Y0.00910Y0.0090.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.905-0.905
TTM-1.157-1.157
YOY-1.747-1.747
5Y0.0092.393-2.384
10Y0.0093.418-3.409
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Er Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Er Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Er Therapeutics Inc to Other Industrial Metals & Mining industry mean.
  • A Debt to Asset Ratio of 1.27 means that Er Therapeutics Inc assets are financed with 126.5% credit (debt) and the remaining percentage (100% - 126.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Er Therapeutics Inc:

  • The MRQ is 1.265. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.265. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.265TTM1.2650.000
TTM1.265YOY0.825+0.440
TTM1.2655Y1.116+0.149
5Y1.11610Y1.1160.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2650.200+1.065
TTM1.2650.200+1.065
YOY0.8250.180+0.645
5Y1.1160.228+0.888
10Y1.1160.261+0.855
4.5.4.2. Debt to Equity Ratio

Measures if Er Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Er Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.726-4.726
TTM-5Y6.810-6.810
5Y6.81010Y6.8100.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.183-0.183
TTM-0.187-0.187
YOY4.7260.192+4.534
5Y6.8100.240+6.570
10Y6.8100.293+6.517
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Er Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Er Therapeutics Inc to the Other Industrial Metals & Mining industry mean.
  • A PE ratio of -6.96 means the investor is paying $-6.96 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Er Therapeutics Inc:

  • The EOD is -0.014. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.960. Based on the earnings, the company is expensive. -2
  • The TTM is -6.960. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.014MRQ-6.960+6.946
MRQ-6.960TTM-6.9600.000
TTM-6.960YOY--6.960
TTM-6.9605Y-1.740-5.220
5Y-1.74010Y-1.7400.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
EOD-0.014-3.575+3.561
MRQ-6.960-4.684-2.276
TTM-6.960-5.149-1.811
YOY--7.144+7.144
5Y-1.740-10.602+8.862
10Y-1.740-11.620+9.880
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Er Therapeutics Inc:

  • The EOD is -0.025. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -12.948. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.948. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.025MRQ-12.948+12.922
MRQ-12.948TTM-12.9480.000
TTM-12.948YOY--12.948
TTM-12.9485Y-3.237-9.711
5Y-3.23710Y-3.2370.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
EOD-0.025-4.845+4.820
MRQ-12.948-5.437-7.511
TTM-12.948-5.837-7.111
YOY--7.701+7.701
5Y-3.237-12.144+8.907
10Y-3.237-15.624+12.387
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Er Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other Industrial Metals & Mining industry mean).
  • A PB ratio of -26.44 means the investor is paying $-26.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Er Therapeutics Inc:

  • The EOD is -0.052. Based on the equity, the company is expensive. -2
  • The MRQ is -26.444. Based on the equity, the company is expensive. -2
  • The TTM is -26.444. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.052MRQ-26.444+26.392
MRQ-26.444TTM-26.4440.000
TTM-26.444YOY--26.444
TTM-26.4445Y-6.611-19.833
5Y-6.61110Y-6.6110.000
Compared to industry (Other Industrial Metals & Mining)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0521.107-1.159
MRQ-26.4441.245-27.689
TTM-26.4441.396-27.840
YOY-1.854-1.854
5Y-6.6112.540-9.151
10Y-6.6113.126-9.737
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2010-11-30. Currency in USD. All numbers in thousands.

Summary
Total Assets424
Total Liabilities536
Total Stockholder Equity-112
 As reported
Total Liabilities 536
Total Stockholder Equity+ -112
Total Assets = 424

Assets

Total Assets424
Total Current Assets0
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 0
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Property Plant Equipment 413
Long Term Investments 10
Long-term Assets  (as reported)0
Long-term Assets  (calculated)423
+/- 423

Liabilities & Shareholders' Equity

Total Current Liabilities536
Long-term Liabilities0
Total Stockholder Equity-112
Total Current Liabilities
Short Long Term Debt 48
Accounts payable 321
Other Current Liabilities 5
Total Current Liabilities  (as reported)536
Total Current Liabilities  (calculated)374
+/- 162
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock58
Other Stockholders Equity 48
Total Stockholder Equity (as reported)-112
Total Stockholder Equity (calculated)106
+/- 218
Other
Net Tangible Assets -112
Net Working Capital -536



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2010-11-302009-11-302008-11-302007-11-30
> Total Assets 
11
141
454
424
42445414111
   > Total Current Assets 
4
30
4
0
04304
       Cash And Cash Equivalents 
4
30
4
0
04304
       Short-term Investments 
0
0
0
0
0000
   > Long-term Assets 0000
       Property Plant Equipment 
7
1
440
413
41344017
       Long Term Investments 
0
0
10
10
101000
       Other Assets 
0
110
0
0
001100
> Total Liabilities 
11
200
375
536
53637520011
   > Total Current Liabilities 
11
200
375
536
53637520011
       Short Long Term Debt 
0
0
18
48
481800
       Accounts payable 
11
93
180
321
3211809311
       Other Current Liabilities 
0
0
2
5
5200
   > Long-term Liabilities 0000
> Total Stockholder Equity
0
-59
79
-112
-11279-590
   Common Stock
15
48
54
58
58544815
   Retained Earnings Total Equity0000
   Accumulated Other Comprehensive Income 0000
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
0
36
86
48
4886360



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2010-11-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-311
Operating Income-311-311
 
Operating Expense (+$)
Research Development0
Selling General Administrative288
Selling And Marketing Expenses0
Operating Expense311288
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-311
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-427-196
EBIT - interestExpense = -311
-427
-427
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-311-427
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-427
Tax Provision-0
Net Income From Continuing Ops-427-427
Net Income-427
Net Income Applicable To Common Shares-427
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring-5
Other Operating Expenses0
Total Other Income/Expenses Net-1160
 

Technical Analysis of Er Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Er Therapeutics Inc. The general trend of Er Therapeutics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Er Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Er Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.0001 < 0.0001 < 0.0001.

The bearish price targets are: 0.

Tweet this
Er Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Er Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Er Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartEr Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Er Therapeutics Inc. The current adx is .

Er Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Er Therapeutics Inc.

Er Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Relative Strength Index (RSI) ChartEr Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Er Therapeutics Inc.

Er Therapeutics Inc Daily Stochastic Oscillator ChartEr Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Commodity Channel Index (CCI) ChartEr Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartEr Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Er Therapeutics Inc.

Er Therapeutics Inc Daily Williams %R ChartEr Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Er Therapeutics Inc.

Er Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Average True Range (ATR) ChartEr Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Er Therapeutics Inc.

Er Therapeutics Inc Daily On-Balance Volume (OBV) ChartEr Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Er Therapeutics Inc.

Er Therapeutics Inc Daily Money Flow Index (MFI) ChartEr Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Er Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Er Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Er Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Er Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Er Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Er Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Er Therapeutics Inc

I send you an email if I find something interesting about Er Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Er Therapeutics Inc.

Receive notifications about Er Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.